LTX-315liver cancer
…nt efficacy in suppressing tumor progression. Oncolytic peptide LTX-315 is known to elicit a strong antitumor immune response and durab…
3articles mentioning drugs
16drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: LTX-315 ×
LTX-315
This drug is selected. Its supporting articles are shown below.
Articles mentioning LTX-315
3 articles · page 1 of 1VP-315LTX-315BCCbasal cell carcinoma
…esting a reset of the immune switch toward anti-tumor immunity. VP-315 is a promising treatment for non-surgical first line BCC therap…
LTX-315VP-315BCCbasal cell carcinoma (BCC)immunologically cold tumors
…LPs have also shown remarkable clinical efficacy. For instance, LTX-315 (studied as VP-315 in basal cell carcinoma (BCC)) has recently …